Soleno Therapeutics (SLNO) Change in Cash: 2013-2024
Historic Change in Cash for Soleno Therapeutics (SLNO) over the last 12 years, with Dec 2024 value amounting to -$81.8 million.
- Soleno Therapeutics' Change in Cash fell 23.27% to $9.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$2.4 million, marking a year-over-year decrease of 139.67%. This contributed to the annual value of -$81.8 million for FY2024, which is 152.72% down from last year.
- According to the latest figures from FY2024, Soleno Therapeutics' Change in Cash is -$81.8 million, which was down 152.72% from $155.1 million recorded in FY2023.
- Soleno Therapeutics' Change in Cash's 5-year high stood at $155.1 million during FY2023, with a 5-year trough of -$81.8 million in FY2024.
- Over the past 3 years, Soleno Therapeutics' median Change in Cash value was -$6.7 million (recorded in 2022), while the average stood at $22.2 million.
- In the last 5 years, Soleno Therapeutics' Change in Cash slumped by 198.00% in 2021 and then spiked by 2,413.92% in 2023.
- Over the past 5 years, Soleno Therapeutics' Change in Cash (Yearly) stood at $28.5 million in 2020, then tumbled by 198.00% to -$27.9 million in 2021, then surged by 76.00% to -$6.7 million in 2022, then soared by 2,413.92% to $155.1 million in 2023, then plummeted by 152.72% to -$81.8 million in 2024.